Actively Recruiting
Home Blood Pressure Intervention in the Community Trial
Led by Shanghai Institute of Hypertension · Updated on 2025-01-06
10000
Participants Needed
1
Research Sites
373 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary purpose of the study is to explore whether a lower home blood pressure target (125/75 v.s. 135/85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.
CONDITIONS
Official Title
Home Blood Pressure Intervention in the Community Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 60-80 years old
- Have been taking antihypertensive drugs for more than 2 weeks
- Average systolic and/or diastolic blood pressure of 135/85 mmHg or higher based on 7-day home blood pressure monitoring
- Willing to participate, follow up regularly, and sign the informed consent form
You will not qualify if you...
- Arm circumference too small (less than 18 cm) or too large (greater than 42 cm) to fit the blood pressure cuff
- Invalid home blood pressure monitoring (less than 3 consecutive days with at least 1 morning and 1 evening measurement per day)
- Office blood pressure at stage 3 hypertension level (180/110 mmHg or higher) during screening
- Suspected or confirmed secondary hypertension
- Orthostatic hypotension defined as a drop in systolic blood pressure over 20 mmHg or diastolic over 10 mmHg within 3 minutes of standing
- Severe kidney disease with eGFR less than 30 ml/min/1.73m2 or end-stage renal disease
- Cardiovascular events such as heart attack, stroke, acute heart failure, unstable angina hospitalization, or coronary artery procedures within the past 3 months
- Abnormal liver function tests more than twice the normal limit
- Severe serious illness with less than 3 years life expectancy or cancer diagnosis within the past 2 years requiring treatment
- Participation deemed harmful or poor compliance expected by doctors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Community hospitals
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
Y
Yan Li, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here